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CyclinD1Formation of the mammalian secondary palate is a highly regulated and complex process. Impairment of the
underlying cellular and molecular programs often results in cleft palate, a common birth defect in mammals.
Here we report that Tbx2 and Tbx3, two closely related genes encoding T-box transcription factors, are
expressed in the mesenchyme of the mouse palatal structures during development. Mice homozygous
mutant for Tbx2 and mice double heterozygous for Tbx2 and Tbx3 exhibit a cleft palate phenotype arguing
for an important contribution of Tbx2 and Tbx3 to palatogenesis. In Tbx2-deﬁcient embryos, the bilateral
primordial palatal shelves form but are smaller and retarded in the outgrowth process. They do not make
contact but retain the potential to fuse. Development of other craniofacial structures appears normal,
suggesting that impaired palate formation in Tbx2-mutant mice is caused by a primary defect in the palatal
shelf mesenchyme. This is further supported by increased cell proliferation and apoptosis accompanied by
increased expression of Bmp4 and CyclinD1 in Tbx2-deﬁcient palatal shelves. Hence, Tbx2 and Tbx3 function
overlappingly to control growth of the palatal shelf mesenchyme.
© 2009 Elsevier Inc. All rights reserved.Introduction
Cleft palate without or with association of a cleft lip (CP, CL/P) is
the most frequent human birth defect. This complex trait is caused by
multiple genetic disorders but also by environmental perturbations of
the development of the secondary palate (Gritli-Linde, 2007; Murray,
2002). The mammalian secondary palate arises from the medial sides
of the maxillary processes that ﬂank the oral cavity. In the mouse, the
bilateral palatal shelves (PS) initiate outgrowth at embryonic day (E)
11.5 with a vertical movement down the side of the tongue. With the
expansion of the lower jaw, the tongue drops in the oral cavity
providing space for an elevation of the PS.With continued growth, the
PS oppose in the midline and ﬁnally fuse. The multilayered epithelial
seam initially present at the midline subsequently degenerates,
establishing a continuous mesenchyme across the whole roof of the
oral cavity at E15.5 (Ferguson, 1988).
PS morphogenesis depends on survival, continued proliferation,
migration and differentiation of mesenchymal cells and their inter-. Kispert).
ll rights reserved.action with the surrounding epithelial cover. Impairment of any of
these processes will delay or inhibit palatal outgrowth resulting in PS
non-fusion. The failure to separate the oral from the nasal cavity will
lead to early postnatal lethality in mammals (Gritli-Linde, 2007; Rice,
2005).
T-box (Tbx) genes encode a conserved family of transcription
factors that play important roles in numerous processes during
embryonic development including palatogenesis (Naiche et al.,
2005). Phenotypic analyses of mice and human patients have
identiﬁed three family members as critical mediators in this program
to date. Tbx1-deﬁcient mice display a wide range of developmental
anomalies including CP (Jerome and Papaioannou, 2001; Merscher
et al., 2001). The phenotypic spectrum of Tbx1-deﬁcient mice
resembles that of heterozygous patients of DiGeorge/velocardiofacial
syndrome (DGS/VCFS), a common human disorder, usually associ-
ated with deletions of chromosome 22q11 in which TBX1 resides
(Shprintzen et al., 2005). Cleft palate in association with ankyloglos-
sia, a rare disorder with X-linked inheritance (CPX) has recently been
shown to result from mutations in the T-box gene family member
TBX22 (Braybrook et al., 2001). Tbx22-deﬁcient mice have a sub-
mucous cleft palate (SMCP) and ankyloglossia, similar to the human
phenotype, with a small minority showing overt clefts (Pauws et al.,
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CL/P in homozygotes and show signiﬁcantly increased susceptibility
to CL/P in heterozygotes. Chromosomal analysis of the Dc locus
revealed an insertional mutation that causes ectopic expression of a
p23-Tbx10 chimeric transcript indicating that gain of expression of
a T-box transcription factor gene can also cause CP pathogenesis
(Bush et al., 2004).
Tbx2 and Tbx3 encode a closely related pair of T-box proteins
whose high sequence conservation, equivalent function as transcrip-
tional repressors on common DNA binding sites and shared ex-
pression domains suggest that the two genes arose by a recent gene
duplication event during vertebrate evolution (Harrelson et al., 2004;
Naiche et al., 2005). Phenotypic analyses of mutant mice have re-
vealed unique functions of Tbx2 in heart and limb formation
(Aanhaanen et al., 2009; Harrelson et al., 2004) and of Tbx3 in the
development of limbs, yolk sac, mammary gland, heart and liver
(Bakker et al., 2008; Davenport et al., 2003; Hoogaars et al., 2007b;
Ludtke et al., 2009; Suzuki et al., 2008). Expression analysis and organ
culture experiments have implicated Tbx3 in control of cell prolifer-
ation in the PS but an in vivo requirement for Tbx3 has not yet been
shown (Lee et al., 2007). Unfortunately, analysis of compoundmutant
embryos to test the functional redundancy at sites of co-expression of
Tbx2 and Tbx3 has been hampered by the difﬁculty of propagating
mice double heterozygous for both mutant alleles (Jerome-Majewska
et al., 2005).
Here, we extend the functional analysis of T-box genes in mouse
palatogenesis and show that Tbx2 and Tbx3 are co-expressed during
palate formation and are required for the formation of a secondary
palate. Mice homozygous mutant for Tbx2 and mice double hetero-
zygous for Tbx2 and Tbx3 exhibit a CP phenotype arguing for an
important contribution of Tbx2 and Tbx3 to palatogenesis. We deter-
mine the temporal onset of the phenotype and characterize the
underlying histochemical and molecular changes. We conclude that
formation of the mammalian secondary palate like formation of other
organs requires the precise interplay of T-box transcription factor
activities and signaling pathways.
Materials and methods
Mice
Mice carrying a null allele of Tbx2 (Tbx2tm1.1(cre)Vmc, synonym:
Tbx2cre) (Aanhaanen et al., 2009) or Tbx3 (Tbx3tm1.1(cre)Vmc, synonym:
Tbx3cre) (Hoogaars et al., 2007b) were maintained on an NMRI
outbred and FvB/N inbred background, respectively. For the gene-
ration of Tbx2 or Tbx3 mutant embryos, mice heterozygous for either
mutant allele were intercrossed. Mice double heterozygous for Tbx2
and Tbx3 mutant alleles were mated to obtain compound mutant
embryos. Embryos for Tbx2 and Tbx3 expression analysis were
derived from matings of NMRI wildtype mice. For timed pregnancies,
vaginal plugs were checked in the morning after mating, noon was
taken as embryonic day (E) 0.5. Embryos were harvested in PBS, ﬁxed
in 4% paraformaldehyde overnight and stored in 100% methanol at
−20 °C before further use.Wildtype littermateswere used as controls.
Genomic DNA prepared from yolk sacs or tail biopsies was used for
genotyping by PCR (Hoogaars et al., 2007b).
Organ culture
PS were isolated from E12.5 mouse maxillae and cultured in
medium with fetal bovine serum at 37 °C and 5% CO2 for 48 h using a
slightmodiﬁcation of the culturemethod reported by Trowell (Taya et
al., 1999). The culture medium (DMEM/F12, Gibco) was supplemen-
ted with 20 μg/ml ascorbic acid (Sigma) and 1% penicillin/
streptomycin. Tissues were then ﬁxed and processed for histological
analysis.Histological analysis
Heads of the embryos and organ culture tissues were embedded in
parafﬁn wax and sectioned to 5 μm. Sections were stained with
hematoxylin and eosin.
Cellular assays
Cell proliferation in tissues of E12.5 and E14.0 embryos was
investigated by the detection of incorporated BrdU on 5-μm sections
of parafﬁn wax-embedded specimens, similar to published protocols
(Bussen et al., 2004). Four sections each of anterior and posterior
palate were taken from three embryos of each genotype at both stages
for quantiﬁcation. The BrdU-labeling indexwas deﬁned as the number
of BrdU-positive nuclei relative to the total number of nuclei as
detected by DAPI counterstain in the mesenchyme of PS tip region.
Detection of apoptotic cells in 5-μm parafﬁn sections of E11.5-14.0
embryos was based on the modiﬁcation of genomic DNA using
terminal deoxynucleotidyl transferase (TUNEL assay) and indirect
detection of positive cells by ﬂuorescein-conjugated anti-digoxigenin
antibody. The procedure followed exactly the recommendation of the
manufacturer (Serologicals Corp.) of the ApopTag kit used. The rate of
apoptosis was deﬁned as the number of TUNEL positive nuclei relative
to the total number of nuclei as detected by DAPI counterstain in the
mesenchyme of PS tip region. Cell densities in the PSwere determined
by counting DAPI-positive nuclei in a deﬁned square of 60×80 μm
centered in the PS tip region. PS size was measured using ImageJ
software (NIH freeware). Statistical analysis was performed using the
two-tailed Student's t-test. Data were expressed as mean +/−
standard deviation. Differences were considered signiﬁcant (⁎) when
the P-value was below 0.05 and highly signiﬁcant (⁎⁎) when the
P-value was below 0.005.
In situ hybridization analysis
Whole mount in situ hybridization analysis was performed with
digoxigenin-labeled antisense riboprobes following a standard pro-
cedure (Wilkinson, 1992). Stained specimens were transferred into
80% glycerol prior to documentation. In situ hybridization analysis on
10-μm frontal sections of embryo heads followed a previously des-
cribed protocol (Moorman et al., 2001).
Semiquantitative reverse transcription PCR
Total RNA was extracted from microdissected E12.5 and E14.0 PS
with RNAPure reagent (Peqlab). RNA (100–500 ng) was reverse
transcribed with RevertAid M-MuLV Reverse Transcriptase (Fermen-
tas). For semiquantitative PCR, the number of cycles was adjusted to
the midlogarithmic phase for each PCR independently. Expression
levels were normalised to Hprt expression. Quantiﬁcation was per-
formed with Quantity One software (Bio-Rad). Assays were per-
formed in duplicates and with two different concentrations of cDNA
on three independent pools of four PS each. Statistical analysis was
performed using the two-tailed Student's t-test. Data were expressed
as mean ± standard deviation. Differences were considered signiﬁ-
cant (⁎) when the P-value was below 0.05 and highly signiﬁcant (⁎⁎)
when the P-value was below 0.005.
Primers and PCR conditions are available on request.
Documentation
Whole mount specimens were photographed on a Leica M420
microscope with a Fujix digital camera HC-300Z. Sections were
photographed using a Leica DM5000 microscope with a Leica
DFC300FX digital camera. All images were processed in Adobe
Photoshop CS.
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Tbx2 and Tbx3 are co-expressed in the developing palate
Earlier studies have reported expression of Tbx2 and Tbx3 in
facial primordia at E9.5 (Chapman et al., 1996) and of Tbx3 in PS
mesenchyme at E13.5 and E14.5 of mouse development (Lee et al.,
2007). However, a detailed analysis of expression of the two genes
during development of the maxilla and the secondary palate has not
yet been documented. We therefore analyzed expression of the two
genes during all stages of palate development using in situ
hybridization analysis (Fig. 1). Analysis of whole heads revealed
high expression of Tbx2 and Tbx3 in all prominences of the
developing face, including the fronto-nasal process, the maxillary
process and the cranial half of the mandible from E9.5 to E11.5 (Figs.
1A–E, G). At E11.5, PS primordia became ﬁrst visible as outgrowths of
the maxillary processes on the oral side (Figs. 1E–H). Tbx2 and Tbx3
were expressed on all following stages of outgrowth (E11.5–E14.0),
elevation (E14.0–E14.5) and fusion (E14.5–E15.5) in the PS (Figs. 1I–
X). Expression of Tbx2 and Tbx3 was conﬁned to the mesenchymal
core of the PS (Figs. 1F, H, J, L, N, P, R, T) with Tbx3 expression
extending slightly more laterally in the posterior PS region than that
of Tbx2 (arrows in Figs. 1I, K, M, O, Q, S). After completion of the
fusion process at E15.5, expression persisted in the rugae of theFig. 1. Tbx2 and Tbx3 are co-expressed during palate development. RNA in situ hybridization
Q, S, U, W) and on adjacent frontal sections (F, H, J, L, N, P, R, T, V, X). (E, G, I, K, M, O, Q, S, U
indicated. Black bars indicate section planes shown in the adjacent image; (F, H, J, L, N, P, R, T,
indicated. Tbx2 and Tbx3 are co-expressed in the mesenchyme of the facial processes and in
Tbx3 (K, O, S) expression in the PS. Ea, ear vesicle; eye, eye vesicle; fnp, frontonasal process; m
psp, palatal shelf primordium; ps, palatal shelf; ru, rugue; to, tongue.palate and in the mesenchyme around the midline epithelial seam
(Figs. 1U–X).
Tbx2 and Tbx3 are required for palate development
Co-expression of Tbx2 and Tbx3 during palatogenesis argued for a
possible functional overlap of the two genes in this process. Previous
studies reported embryonic lethality of Tbx2tm1Pa/tm1Pa mice at E14.5
and of Tbx3tm1Pa/tm1Pa mice between E11.5 and E14.5 due to
cardiovascular defects (Davenport et al., 2003; Harrelson et al.,
2004), precluding analysis of a requirement of either gene in
palatogenesis. We wondered whether embryonic viability could be
extended beyond completion of palatogenesis by maintaining null
alleles of Tbx2 (Tbx2cre) (Aanhaanen et al., 2009) and Tbx3 (Tbx3cre)
(Hoogaars et al., 2007a) on an NMRI outbred rather than on a mixed
inbred C57/129/ICR background as used in the previous studies
(Davenport et al., 2003; Harrelson et al., 2004). Indeed, Tbx2cre/cre
embryos maintained on NMRI background exhibited less severe
cardiac defects at E14.5, were viable and represented in the expected
Mendelian ratio at E18.5 (Aanhaanen et al., 2009). Tbx2cre/cre mice
showed a bilateral hindlimb-speciﬁc duplication of digit IV (data
not shown), consistent with previous observations in the Tbx2tm1Pa
strain (Harrelson et al., 2004). Inspection of whole heads and of
frontal sections at E18.5 and E15.5 revealed a complete (isolated) cleftanalysis for Tbx2 and Tbx3 expression was carried out on whole heads (A–E, G, I, K, M, O,
, W) show ventral views of the upper jaw region, the posterior (p)–anterior (a) axis is
V, X) sections show higher magniﬁcation of the left PS, the dorsal (d)–ventral (v) axis is
the PS throughout development. Arrows indicate the spatial extent of Tbx2 (I, M, Q) and
es, midline epithelial seam; mn, mandible; mx, maxilla; nc, nasal cavity; oc, oral cavity;
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(Figs. 2A–D) proving a requirement for Tbx2 in secondary palate
development.
Mice homozygous for the Tbx3cre null allele maintained on NMRI
outbred background, similar to Tbx3tm1Pa/tm1Pa embryos on C57/129/
ICR background, died around E14.5 most likely due to a combination
of cardiac, vascular and hepatic defects (Davenport et al., 2003; Ludtke
et al., 2009; Suzuki et al., 2008). In the one embryo that survived
until E15.5, the PS were fused in the middle region but not anteriorly
(Figs. 2E–I) suggesting that PS growth and fusion occur normally but
may be delayed due to the general developmental retardation of these
embryos. Since a conditional approach is not available to date to
stringently test the individual requirement of Tbx3 in palatogenesis,
we analyzed embryos compoundmutant for Tbx2 and Tbx3 for defects
in this process.
Mice heterozygous for Tbx2cre or Tbx3cre alleles were pheno-
typically normal on the NMRI outbred background they were main-
tained on. In contrast, 38% (5 of 13) of Tbx2cre/+Tbx3cre/+ embryos
harvested at E18.5 exhibited a complete CP suggesting a crucial
but less important contribution of Tbx3 to palatogenesis than Tbx2
(Figs. 2J–M). The few embryos with three or four mutant alleles of
Tbx2 and Tbx3 obtained from intercrosses of Tbx2cre/+Tbx3cre/+
mice died at E10.5 due to hemodynamic failure precluding further
analysis of the redundant role of the two genes in secondary palate
development. Cardiovascular defects observed in these embryos are
in agreement with a redundant function of the two genes in theFig. 2. Requirement of Tbx2 and Tbx3 in the development of the secondary palate. Analysis o
regions at E18.5 (A, B, J, K, N, O) and at E15.5 (E), the posterior (p)–anterior (a) axis is indica
at E18.5 (C, D, L, M, P, Q) and at E15.5 (F–I), the dorsal (d)–ventral (v) axis is shown. Secti
genetic backgrounds (NMRI or FvB/N) are as indicated in the ﬁgure. 85% of Tbx2cre/cre embr
86% of Tbx2cre/+Tbx3cre/+ on FvB/N genetic background (P, Q) but not Tbx3cre/cre embryos on
septum; oc, oral cavity; p, palate; ps, palatal shelf; to, tongue.formation of the atrioventricular canal and will be presented
elsewhere.
Mice double heterozygous for null alleles of Tbx2 and Tbx3
that were maintained on an FvB/N genetic background exhibited
cleft palate with a penetrance similar to Tbx2 single mutants (85%, 11
of 13) (Figs. 2N–Q) arguing for a strong contribution of the genetic
background to CP etiology in Tbx2- and Tbx3-deﬁcient mice.
Tbx2-deﬁcient mice exhibit retardation of PS elevation
To investigate which step of secondary palate formation is
disturbed in Tbx2cre/cre embryos, we carried out a detailed morpho-
logical and histological analysis throughout palate development
(Fig. 3). At E12.5, no obvious difference in morphology and histology
of the PS was observed betweenwildtype and Tbx2-deﬁcient embryos
(Figs. 3A–D). At E13.5, PS of Tbx2-deﬁcient embryos appeared smaller
and had moved less down the tongue compared to the wildtype
(Figs. 3E–H). PS of wildtype embryos were elevated at E14.25 (Figs. 3I,
K) and fused between E14.5 and E15.5 (Figs. 3M, O, Q, S). In contrast,
in Tbx2-deﬁcient embryos morphogenesis of the smaller PS was
severely retarded and eventually came to a premature hold as
evidenced by the appearance of elevated shelves only at E14.5 that
failed to undergo the fusion process (Figs. 3J, L, N, P, R, T). The failure
of PS fusion may be caused by a direct requirement for Tbx2 in the
fusion process or by physical constrain due to the increased distance
between the shelves. We tested these possibilities by juxtaposing PSf defects in cleft palate formation in embryos by morphological inspection of upper jaw
ted; and by histological staining with hematoxylin and eosin of frontal sections of heads
on planes are indicated by black bars in whole upper jaw preparations. Genotypes and
yos (B, D) and 38% of Tbx2cre/+Tbx3cre/+ (K, M) embryos on NMRI genetic background,
NMRI background (G, I) show a complete isolated cleft of the secondary palate. ns, nasal
Fig. 3. Retardation of PS growth in Tbx2-deﬁcient embryos. Morphological (left two columns, the posterior (p)–anterior (a) axis is indicated) and histological (right two columns, the
dorsal (d)–ventral (v) axis is shown) analysis of secondary palate formation in wildtype and Tbx2cre/cremice. Developmental stages and genotypes are as indicated. In Tbx2-deﬁcient
embryos, PS are smaller, their outgrowth and elevation is retarded and fusion does not occur. md, mandible; mes, midline epithelial seam; ns, nasal septum; oc, oral cavity; ps, palatal
shelf; to, tongue.
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system for 48 h. Under these conditions the PS of the Tbx2cre/cre
embryos fused as readily as the wildtype control (Fig. 4). Hence, loss
of Tbx2 function primarily affects growth but not fusion of the PS.
Tbx2 plays a role in survival and proliferation of the PS mesenchyme
In agreement with the histological observations (Fig. 3) quantita-
tive analysis of PS size revealed no change at E12.5 but a signiﬁcant
reduction in the anterior region at E14.0 in Tbx2-deﬁcient embryos
(Fig. 5A). Cell densities in both anterior and posterior aspects of the PS
was not signiﬁcantly altered at both time points between wildtype
and Tbx2cre/cre embryos (Fig. 5B). To investigate the cellular mechan-
isms that may underlie the decreased size and the retardation in PS
morphogenesis in Tbx2-deﬁcient embryos, we analyzed cell prolifer-Fig. 4. Tbx2-deﬁcient PS retain fusion competence. Histological analysis by hematoxylin and e
Tbx2cre/cre PS undergo fusion as in the control. Arrows indicate position of former midline eation in the PS mesenchyme using the BrdU incorporation assay (Fig.
5C). We detected a signiﬁcant increase of the cell proliferation rate
from 19.5% to 25.4% in the anterior but not in the posterior PS region
of Tbx2-deﬁcient mice at E12.5. At E14.0, cell proliferation was not
signiﬁcantly changed throughout the PS mesenchyme compared to
control embryos (Fig. 5C).
We further performed TUNEL assays to analyze the role of
apoptosis for the defect in shape and morphogenesis of PS in the
Tbx2-deﬁcient embryos (Fig. 6). We compared the situation in
homozygous Tbx2-mutant embryos with that of wildtype as well as
of heterozygous control embryos to exclude a contribution of Cre
expression to changes in cell survival (Naiche and Papaioannou,
2007). We detected increased apoptosis throughout the PS mesen-
chyme at E11.5 and in the anterior PS region at E12.5 of Tbx2cre/cre
embryos. At E13.5 and E14.0, apoptosis was unchanged compared toosin stainings of sections of 48 h cultures of juxtaposed PS isolated from E13.5 embryos.
pithelial seam.
Fig. 5. Changes of PS size, cell density and proliferation in Tbx2cre/cre embryos. (A) Analysis of PS size, measured on frontal sections of wildtype (black column) and Tbx2-
deﬁcient embryos (white column) at E12.5 (left panel) and E14.0 (right panel). PS size at E12.5 did not show highly signiﬁcant differences anteriorly or posteriorly (anterior:
wt: 0.0157±0.002 mm2, mut: 0.0187±0.004 mm2, p=0.03; posterior: wt: 0.0434±0.007 mm2, mut: 0.0397±0.009 mm2, p=0.19). At E14.0, the PS size was signiﬁcantly
decreased in the anterior and posterior region (anterior: wt: 0.0472±0.0087 mm2, mut: 0.0188±0.0023 mm2, pb0.0001; posterior: wt: 0.0718±0.0106 mm2, mut: 0.0626±
0.0093 mm2, pb0.005). (B) Cell densities were not signiﬁcantly changed at E12.5 (anterior, wt: 13791±1416 cells/mm2, mut: 12416±3024 cells/mm2, p=0.209; posterior,
wt: 13541±1725 cells/mm2, mut: 12041±878 cells/mm2, p=0.023) and at E14.0 (anterior: wt: 9948±1107 cells/mm2, mut: 10833±1339 cells/mm2, p=0.294; posterior,
wt: 11125±2524 cells/mm2, mut: 11718±1510 cells/mm2, p=0.547). (C) Analysis of cell proliferation in frontal sections of the palate region of wildtype (wt) and Tbx2-
deﬁcient (Tbx2cre/cre) embryos at E12.5 (left panel) and E14.0 (right panel) by the BrdU incorporation assay. The PS region used for quantiﬁcation is shown in the histological
sections. Quantiﬁcation of cell proliferation was performed by the ratio of BrdU-positive cells to total cell number as determined by DAPI counterstain, the BrdU-labeling index,
in the analyzed area at an anterior and posterior position in the PS. The BrdU labeling index is signiﬁcantly increased in the anterior region of the Tbx2-mutant PS mesenchyme
at E12.5 (wt: 19.5±0.4, mut: 25.4±0.9, pb0.0001), while in the posterior region at this stage (wt: 22.5±1.7, mut: 26.0±1.6, p=0.15), and at E14.0 in the anterior region
(wt: 22.2±0.4, mut: 23.0±0.5, p=0.023) and in the posterior region (wt: 30,3±0.6, mut: 28.0±0.6, p=0.009) no signiﬁcant changes were detected.
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survival precede morphological and histological alteration of PS
morphology and growth.
Bmp4 and Ccnd1 expression are up-regulated in Tbx2-deﬁcient PS
To analyze the molecular changes underlying disturbed PS
formation in Tbx2cre/cre embryos, we analyzed expression of a large
panel of genes which mutational analyses in the mouse implicated
in the palatal growth process (Gritli-Linde, 2007) by in situ hybri-
dization analysis of sections and whole heads between E12.5 and
E14.0.
Bone morphogenetic protein 2 and 4 (Bmp2 and Bmp4) and their
target gene homeobox, msh-like 1 (Msx1) are weakly expressed in the
PS mesenchyme where they regulate in an autoregulatory loop
proliferation mainly in the anterior region (Zhang et al., 2000, 2002).
Notably, Msx1 and Tbx2/Tbx3 are targets genes of Bmp signaling in a
variety of tissues including the atrioventricular canal (Yamada et al.,
2000) where the encoded proteins form complexes to repress
transcription of genes (Boogerd et al., 2008). Expression of Bmp2
and Msx1 as well as distribution of phospho-Smad1,5,8, the
intracellular mediator of Bmp signaling, appeared unchanged in the
Tbx2-deﬁcient palate (Supplemental Fig. 1). Bmp4 levels appeared
slightly elevated in some of our experiments (Fig. 7A).
Mesenchymal ﬁbroblast growth factor 10 (Fgf10) signaling
regulates proliferation in the PS mesenchyme and epithelium.Interestingly, Fgf10 activates sonic hedgehog (Shh) expression in the
epithelium that in turn signals back into the mesenchyme (Rice et al.,
2004). Expression of Shh in the PS epithelium, and of Fgf10, the
intracellular Fgf inhibitor gene sprouty homolog 2 (Drosophila)
(Spry2), the Fgf target ets variant gene 4 (Etv4 or Pea3) and of the
Shh target gene patched homolog 1 (Ptch1) in the PS mesenchyme was
unaffected in the mutant arguing against an involvement of Fgf- and
Shh-signalling pathways in the etiology of CP in Tbx2-deﬁcient mice
(Supplemental Figs. 2 and 3).
It was recently shown that loss of Eph receptor B1 (Ephb1) alone or
compound loss of Ephb2 and Ephb3 signaling also affects palate
growth and elevation (Orioli et al., 1996; Risley et al., 2009).
Expression of these genes as well as other members of the families
of Eph receptor A and B genes, and the ephrin A and ephrin B ligand
genes was unchanged in the mutant PS mesenchyme (Supplemental
Figs. 4 and 5). Finally, expression ofwingless-related MMTV integration
site 5A gene (Wnt5a) that was recently implicated in cellular
proliferation and migration in the developing palate (He et al.,
2008) was similarly unaffected (Supplemental Fig. 6).
PS are regionalized into an anterior and a posterior compartment.
Short stature homeobox 2 (Shox2) is expressed in the anterior PS
mesenchyme at E12.5 and E13.5 (Hilliard et al., 2005; Yu et al., 2005).
In contrast, Tbx22 expression is found in the midposterior mesen-
chyme at E12.5 and posteriorly at E13.5 (Braybrook et al., 2002; Bush
et al., 2002; Herr et al., 2003). Paired box gene 9 (Pax9) is expressed
along the anterior-posterior extent of the PS mesenchyme with an
Fig. 6. Changes of apoptosis in Tbx2cre/cre PS. TUNEL assay on frontal sections through the head detects increased apoptosis in the entire PS mesenchyme of Tbx2-deﬁcient embryos at
E 11.5 (A, left panel) (anterior: wt: 0.18±0.18, mut: 3.68±0.79, p=0.00005; posterior: wt: 1.26±0.38, mut: 1.47±0.51, p=0.69) and in the anterior part at E12.5 (B, left panel)
compared to wildtype and heterozygous controls (wt: 0.21±0.13, mut: 1.55±0.08, p=0.001). Apoptosis was unchanged in the posterior portion at E12.5 (A, right panel; B, right
panel) (wt: 0.17±0.26), mut: 0.53±0.34, p=0.27) between controls and Tbx2-deﬁcient embryos.
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three markers was unchanged in the mutant arguing that anterior–
posterior PS regionalization is not controlled by Tbx2 (Supplemental
Fig. 7).
Odd-skipped related 1 and 2 (Osr1 and Osr2) encode transcription
factors that are expressed and required for proliferation in the PS
mesenchyme (Lan et al., 2001, 2004). Both genes showed unaltered
expression in the Tbx2-deﬁcient palate at E12.5-E14.0 (Supplemental
Fig. 8).
We additionally tested expression of genes directly regulating cell
cycle progression and proliferation since Tbx2 has been implicated in
cell cycle control in other contexts (Bilican and Goding, 2006; Jerome-
Majewska et al., 2005). Expression of CyclinD2 (CycD2, Ccnd2), Cy-
clinD3 (CycD3, Ccnd3), of cyclin-dependent kinase inhibitor 2A (Cdkn2a
or p16Ink), 2C (Cdkn2c or p18), 2D (Cdkn2d or p19Arf) and of cyclin-
dependent kinase inhibitor 1A (Cdkn1a or p21Waf), 1B (Cdkn1b or
p27Kip1), 1C (Cdkn1c or p57Kip2) was not detectably altered by loss
of Tbx2 in the PS mesenchyme in this assay (Supplemental Fig. 9).
Expression of CyclinD1 (CycD1, Ccnd1), however, appeared up-
regulated (Fig. 7B).
Analysis of chondrogenesis by in situ hybridization of the chon-
drogenic regulator SRY-box containing gene 9 (Sox9) and its target
gene collagen type II, alpha 1 (Col2a1) and histochemical analysis
of ECM composition by Alcian blue staining revealed no distur-
bance of chondrogenesis in the Tbx2-deﬁcient PS (Supplemental
Figs. 10 and 11).
In order to conﬁrm and expand this molecular phenotype analysis,
we additionally employed a semiquantitative RT-PCR analysis on
mRNA of microdissected whole PS from E12.5 and E14.0 embryos
(Figs. 7C, D). In the later case, we used independent pools from
anterior and posterior PS regions. We successfully established PCRs
for most of the genes that have been implicated or are likely to be
involved in growth control of the PS mesenchyme including genes of
the Bmp (Bmp2, Bmp4, Msx1), and Fgf pathways (Fgf10, Spry2, Pea3),Osr genes (Osr1, Osr2), and cell cycle control genes (CycD1, CycD2,
CycD3, p16Ink, p19Arf, p21Waf, p27Kip1, p27Kip2). We omitted genes
the spatially restricted expression of which cannot be properly
reﬂected in this assay (Pax9, Tbx22, Shox2, Shh, Ptch1).
RT-PCR analysis reliably identiﬁed signiﬁcant up-regulation of
Bmp4 (1.7 fold) and CyclinD1 (3.2 fold) expression in Tbx2-deﬁcient
PS at E12.5 (Fig. 7C) conﬁrming the results of our in situ hybridization
assays (Figs. 7A, B). All other genes tested were unchanged at both
time points (Figs. 7C, D) again in agreement with our in situ
hybridization data (Supplemental Figs. 1, 2, 8, and 9). Thus, our
analyses excludes a number of signaling pathways including Fgf, Shh,
Wnt and Ephrins as molecular mediators of the defects in secondary
palate development in Tbx2-deﬁcient mice.
Since CyclinD1 has been characterized as a factor positively
inﬂuencing cellular proliferation, its elevated expression can explain
the observed proliferation increase in the E12.5 anterior PS mesen-
chyme of Tbx2-deﬁcient embryos. Bmp-signaling affects a large
number of cellular processes in diverse embryonic context. Notably,
elevated levels of Bmp have been shown to induce apoptosis in a
number of tissues but may also affect cellular proliferation (Kiyono
and Shibuya, 2006; Koide et al., 2009; Lagna et al., 2006; Mukho-
padhyay et al., 2006). Thus, dysregulation of cell proliferation and
apoptosis in Tbx2-deﬁcient PS mesenchyme possibly caused by
altered levels of CyclinD1 and Bmp4 expression in the early outgrowth
phasemay translate to alteredmorphology andmorphogenesis of this
tissue, ﬁnally resulting in a CP phenotype.
Discussion
CP is the most frequent human birth defect caused by genetic and
environmental perturbations of the development of the secondary
palate. Recovery of more than 60 gene loci in the mouse the mutation
of which causes this phenotype has allowed the assignment of speciﬁc
molecular and cellular pathways that control palate development
Fig. 7. Molecular changes in palate development in Tbx2-deﬁcient embryos. (A, B) RNA in situ hybridization analysis for Bmp4 and CyclinD1 expression in PS at E12.5. Images show
expression on sections through the anterior, middle and posterior region of PS with dorsal oriented upwards. Bmp4 and CyclinD1 expression appears increased in the anterior region of
PS. (C, D) Quantitative RT-PCR analysis detects molecular changes in Tbx2-deﬁcient PS at E12.5 (C) but not at E14.5 (D). QRT-PCR analysis of marker genes was done on mRNA from
E12.5 and E14.0 PS as indicated in the ﬁgure. Expression levels are relative to the wildtype/heterozygous control pool (100%). Expression of Bmp4 and CyclinD1 is signiﬁcantly up-
regulated with a mean±SD for Bmp4 of 1.798±0.2802, p=0.0154 and 3.210±0.7005, p=0.0069 for CyclinD1. All other tested genes remained unchanged in the Tbx2cre/cre embryo.
152 S. Zirzow et al. / Developmental Biology 336 (2009) 145–155(reviewed in Gritli-Linde, 2007). Here, we have shown that Tbx2 and
Tbx3, two closely related T-box transcription factor genes, are
speciﬁcally required for PS growth during secondary palate develop-
ment. Increased apoptosis and altered proliferation may be cellularmediators of this phenotype, while increased expression of CyclinD1
and Bmp4 may be a molecular cause. Our identiﬁcation adds to the
complexity of the T-box transcription factor network controlling
mammalian palate development.
153S. Zirzow et al. / Developmental Biology 336 (2009) 145–155Genetic control of PS growth
Palatogenesis is a multistep process that comprises an initial
bilateral expansion of the mandibulary processes followed by a
complex growth program of the PS before a fusion process takes
place. Developmental analysis of our Tbx2-deﬁcient embryos
showed that PS vertical outgrowth and elevation occurred but
were severely delayed while the fusion potential of the shelves was
unaffected. Disturbed proliferation and apoptosis in the Tbx2-
deﬁcient palate at E11.5 to 12.5 indicates a requirement for Tbx2
in tissue growth by maintaining the cell number during the initial
outgrowth phase. Even slight changes of this cellular parameter are
likely to accumulate and translate into a morphogenetic halt as
evidenced by the large number of CP phenotypes associated with
changes of cellular survival and proliferation (Chou et al., 2004;
Gritli-Linde, 2007). Palate development is tightly coupled to the
growth and morphogenesis of the whole craniofacial complex and
disturbances in the development of the later may perturb PS
elevation and result in CP (Chai and Maxson, 2006). Tbx2 and Tbx3
are strongly expressed in all facial primordia, compatible with a
wider requirement for these genes in craniofacial development. Yet,
our histological analysis has not revealed any gross defects outside
the secondary palate pointing to primary role for Tbx2 and Tbx3 in
palatogenesis.
PS growth and morphogenesis are controlled by a complex
interplay of several epithelial and mesenchymal signaling pathways
and their downstream transcriptional mediators (Gritli-Linde,
2007). Tbx2 and Tbx3 are speciﬁcally expressed in the mesenchyme
of the developing secondary palate pointing to regulation by
epithelial and/or mesenchymal signals and a function in the
mesenchyme itself. Tbx2 and Tbx3 are targets of Bmp-signaling in a
number of embryonic contexts including the limb and the atrioven-
tricular canal (Behesti et al., 2006; Ma et al., 2005; Yamada et al.,
2000). Notably, Lee et al. (2007) have recently shown that Bmp4
induces Tbx3 expression and that ectopic Tbx3 in turn down-
regulates Bmp4 in a palate culture system. Our molecular charac-
terization of Tbx2-deﬁcient PS revealed a signiﬁcant up-regulation of
Bmp4 in this tissue supporting the notion that Tbx3 and Tbx2 are
involved in a negative feedback loop with Bmp4. Zhang et al. (2002)
recently showed that Bmp4 and its target gene Msx1 engage in a
positive feedback loop arguing for a complex network to tightly
control expression of this potent signaling molecule. Since we did
not detect changes of Msx1 expression in our assays, Tbx2/Tbx3 and
Msx1 may represent independent and differently sensitive targets of
Bmp-signaling in the PS mesenchyme. Unchanged levels of P-
Smad1,5,8 do not exclude that Bmp-signaling is augmented since
alternative pathways (including p38 MAPK) are known to operate
downstream of the ligand activated receptors (Xu et al., 2008).
Increased proliferation in the anterior PS mesenchyme of E12.5
Tbx2cre/cre embryos may be caused by increased Bmp4 levels since
Bmp4 is known to be a powerful mitogen in this tissue (Hilliard et
al., 2005; Zhang et al., 2002). However, elevated levels of Bmp4 have
also been associated with increased apoptosis, which we detected in
early PS outgrowth in Tbx2-deﬁcient embryos (Kiyono and Shibuya,
2006; Koide et al., 2009; Lagna et al., 2006; Mukhopadhyay et al.,
2006). A mitogenic effect of Bmp4 may be mediated or further
enhanced by increased expression of CyclinD1, a regulatory subunit
of CDK4/6 kinases that controls G1-S progression in the cell cycle.
Increased expression of CyclinD1 and increased proliferation in
Tbx2-deﬁcient PS is unexpected since Tbx2 (and Tbx3) have
frequently been associated with the repression of cell cycle inhibitor
genes including p19Arf and p21Waf, thus, cell proliferation and
senescence bypass (Jacobs et al., 2000; Prince et al., 2004). Lee et al.
(2007) have shown that ectopic expression of Tbx3 leads to
increased cellular proliferation in cultures of E13.5 and E14.5 PS.
The ﬁnding that gain of Tbx3 in vitro and loss of Tbx2 in vivo bothlead to increased proliferation is surprising and cannot be explained
at this moment.
It remains unclear how exactly altered proliferation and apoptosis
in early PS development translates in reduced PS size and retarded
outgrowth. At this point, we cannot exclude that the delay in PS
elevation in Tbx2-deﬁcient mice may also be caused by changes of
ECM composition, cytoskeletal architecture or cell movements.
However, histological analysis of the ECM, of Wnt5a expression (He
et al., 2008) and Ephrin signaling (Risley et al., 2009) provided no
indication of an involvement of these factors and parameters in CP
etiology in Tbx2-deﬁcient embryos.
It is noteworthy that the phenotypic penetrance of CP in Tbx2/
Tbx3 compound heterozygous mice was strongly dependent on the
genetic background, the defect being much more frequent on FvB/N
than on NMRI background. We assume that relatively little changes of
Tbx2 and Tbx3 activity levels result in changes in cellular parameters.
However, since PS growth and morphogenesis is exquisitely sensitive
to proliferation changes, even minor changes of cell cycle regulatory
molecules may accumulate over time and translate in a delay of
outgrowth and eventually cleft palate.
T-box genes and palate development
T-box genes regulate tissue and organ development in a complex
manner that may include hierarchal activities, but also independent,
opposing and/or redundant regional functions of individual family
members (Hoogaars et al., 2007a; King et al., 2006). Previous studies
have identiﬁed three T-box genes in human (and mouse) palate
development. Tbx1 seems to act early in patterning and outgrowth
of the pharyngeal pouches preceding secondary palate development.
Tbx22 is expressed in the posterior PS arguing for a role in region-
alization or compartmentalization of the palate in anterior and
posterior halves (Arnold et al., 2006; Braybrook et al., 2002; Bush
et al., 2002; Herr et al., 2003). Expression of Tbx22 depends on
the transcription factor Mn1 that is preferentially required for
posterior palate growth (Liu et al., 2008). Recent analysis of Tbx22-
deﬁcient mice revealed submucous cleft palate (SMCP) and ankylo-
glossia. Only a small minority of the animals showed overt clefts
indicating a less important role in palatogenesis in mice compared
to humans (Pauws et al., 2009). Tbx2 and Tbx3, as shown in this
study, show no regional restricted expression in the palatal mesen-
chyme but may synergize with Tbx22 in the control of cellular
programs important for the elevation process including proliferation
and apoptosis.
Interestingly, ubiquitous overexpression of Tbx10 in the spon-
taneous Dancer mutant or in transgenic mice causes CP (Bush
et al., 2004) arguing that not only loss but also ectopic expression
of T-box genes can result in the same phenotypic consequences. It
is unclear whether Tbx10 acts as a transcriptional activator or
repressor but it is possible that ectopic Tbx10 competes with
endogenous Tbx function in the palate including Tbx1, Tbx2/Tbx3
and Tbx22. A paradigm for this has been established in the heart
where the transcriptional repressor Tbx2 acts by competing with
the transcriptional activation activity of Tbx5 and Tbx20, explain-
ing the dramatic cardiac arrest phenotype in in vivo misexpres-
sion experiments of Tbx2 (Christoffels et al., 2004; Habets et al.,
2002). The effect of ectopic Tbx10 in cleft palate induction is
strongly dose dependent, being much more frequent in homo-
zygous than in heterozygous conditions (Bush et al., 2004). Our
analysis has shown that the function of Tbx2 and Tbx3 is also
strongly dose- and background-dependent arguing that even slight
interference (e.g., by Tbx10) of endogenous T-box transcription
factor function may lead to perturbed palate development. In sum-
mary, it seems clear that the precise temporal and spatial control of
T-box activity levels is mandatory for normal palatogenesis in mice
and man.
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